Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 129-140

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 7, 2004-11 ,pp. : 555-567

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitors: novel anticancer agents

By Mani S.   Wang C.   Wu K.   Francis R.   Pestell R.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1849-1870

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A.   Popa C.   Serewko M.M.   Jones S.J.   Dicker A.J.   Dahler A.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 303-323

Bentham Science Publishers

Access to resources Recommend Favorite